Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$17.37 USD
+0.12 (0.70%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $17.38 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.37 USD
+0.12 (0.70%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $17.38 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Zacks News
Implied Volatility Surging for Sabra Healthcare REIT (SBRA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Sabra Healthcare REIT (SBRA) stock based on the movements in the options market lately.
Implied Volatility Surging for Sabra Health Care (SBRA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Sabra Health Care (SBRA) stock based on the movements in the options market lately.
Sabra Healthcare (SBRA) Beats Q4 FFO and Revenue Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 2.78% and 2.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Q3 FFO and Revenues Miss Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of -5.26% and 10.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Americold Realty Trust Inc. (COLD) Surpasses Q3 FFO Estimates
by Zacks Equity Research
Americold Realty Trust Inc. (COLD) delivered FFO and revenue surprises of 16% and 0.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Park Hotels & Resorts (PK) Q3 FFO and Revenues Surpass Estimates
by Zacks Equity Research
Park Hotels & Resorts (PK) delivered FFO and revenue surprises of 5% and 1.59%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Industrial Logistics Properties Trust (ILPT) Lags Q3 FFO and Revenue Estimates
by Zacks Equity Research
Industrial Logistics Properties Trust (ILPT) delivered FFO and revenue surprises of -30.30% and 1.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Sabra (SBRA) Stock Jumps 5.5%: Will It Continue to Soar?
by Zacks Equity Research
Sabra (SBRA) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might help the stock continue moving higher in the near term.
Sabra Healthcare (SBRA) Surpasses Q2 FFO Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 5.41% and 2.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Q1 FFO and Revenues Beat Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 2.63% and 1.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Easterly Government Properties (DEA) Lags Q1 FFO and Revenue Estimates
by Zacks Equity Research
Easterly Government Properties (DEA) delivered FFO and revenue surprises of -2.94% and 3.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Surpasses Q4 FFO Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 2.78% and 11.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Franklin Street Properties (FSP) Lags Q4 FFO and Revenue Estimates
by Zacks Equity Research
Franklin Street (FSP) delivered FFO and revenue surprises of -16.67% and 2.43%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Down 12.8% in 4 Weeks, Here's Why Sabra (SBRA) Looks Ripe for a Turnaround
by Zacks Equity Research
Sabra (SBRA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Sabra Healthcare (SBRA) Q3 FFO Meet Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 0.00% and -9.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Is Sabra Healthcare (SBRA) a Great Stock for Value Investors?
by Vedika Agarwal
Let's see if Sabra Healthcare (SBRA) stock is a good choice for value-oriented investors right now from multiple angles.
Sabra Healthcare (SBRA) Q2 FFO Surpass Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 2.63% and -0.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for June 11th
by Zacks Equity Research
BLIN, BNR, MOV, BAP and SBRA have been added to the Zacks Rank #5 (Strong Sell) List on June 11, 2021.
New Strong Sell Stocks for April 1st
by Zacks Equity Research
ALE, FLR, SBRA, WRE, and WELL have been added to the Zacks Rank #5 (Strong Sell) List on April 1, 2021
Should You Buy Sabra (SBRA) Ahead of Earnings?
by Zacks Equity Research
Sabra (SBRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Sabra Healthcare (SBRA) Beats Q3 FFO Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 9.52% and -6.01%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Iron Mountain (IRM) Stock Now
by Zacks Equity Research
While Iron Mountain's (IRM) efforts to expand its data-center portfolio will diversify its revenue mix, there has been a slowdown in its service business due to the pandemic-related shutdowns.
SL Green (SLG) Inks Long-Term Lease at One Vanderbilt Avenue
by Zacks Equity Research
SL Green (SLG) is witnessing a decent leasing momentum at its iconic skyscraper One Vanderbilt Avenue. The property, opened in mid-September, is around 70% leased.
Welltower's (WELL) Liquidity Improves, Occupancy Declines
by Zacks Equity Research
While asset sales will improve Welltower's (WELL) near-term liquidity amid these testing times, the challenging operating environment for senior housing is driving occupancy loss.
Plymouth Increases Credit Facility, Lowers Cost of Debt
by Zacks Equity Research
Plymouth (PLYM) extends and expands its credit facilities by $100 million. Moreover, the new unsecured credit facilities will result in lower interest expenses.